Vantis, a Munich, Germany-based digital health company, raised €3.8m in funding.
The round was co-led by btov Partners and firstminute capital with participation from angels such as the founders of think-cell.
The company intends to use the funds to expand operations and development efforts.
Led by Till Jansen, Maximilian Roedel, Ulrich Klank, Dr. Kevin Wiesner, and Priv.-Doz. Dr. Felix Jansen, Vantis provides a digital health application offering digital therapeutics for cardiovascular indications.
The solution enables continuous patient-centred treatment of heart disease through a mobile app personalised for each patient, continuous measurement of relevant vital signs through devices with dedicated Vantis integration and therapy monitoring with automated data analysis complemented by the doctor in the background.